XML 56 R40.htm IDEA: XBRL DOCUMENT
v3.22.2.2

SUPPLEMENTAL CASH FLOW INFORMATION (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Supplemental Cash Flow Elements [Abstract] |
SCHEDULE OF SUPPLEMENTAL CASH FLOW INFORMATION | Supplemental cash flow information for the years ended December 31: SCHEDULE OF SUPPLEMENTAL CASH FLOW INFORMATION
|  | 2021 |  |  | 2020 |
Cash paid for interest |  | $ | - |  |  | $ | 185,000 |
Non-cash investing and financing activities: |  |  |  |  |  |  |  |
Termination of right of use lease asset |  | $ | (744,000 | ) |  | $ | - |
Termination of right of use lease liability |  | $ | 744,000 |  |  | $ | - |
Shares received for loan origination fee |  | $ | (3,000,000 | ) |  | $ | - |
Shares received for prepaid loan interest |  | $ | (2,440,000 | ) |  | $ | - |
Acquisition of APB net assets |  | $ | 38,765,000 |  |  |  | - |
Common A Shares issued for prepaid marketing services |  | $ | - |  |  | $ | 210,000 |
Common A Shares issued for Impact BioMedical |  | $ | - |  |  | $ | 3,132,000 |
Non-controlling interest related to Impact BioMedical |  | $ | - |  |  | $ | 3,910,000 |
Series A Preferred Shares issued for Impact BioMedical |  | $ | - |  |  | $ | 35,187,000 |
Notes receivable settled for assets in lieu of cash |  | $ | - |  |  | $ | 838,000 |

X
- Definition Tabular disclosure of supplemental cash flow information for the periods presented. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SupplementalCashFlowElementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration